DUPIXENT is indicated as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.

Limitations of Use: DUPIXENT is not indicated for the relief of acute bronchospasm.

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved.

Return to Exhibit Hall

RESOURCES

Contact

Visit Website